Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 5, 1996, Pages 805-813

  Clark, Abbot F ^a   Lane, Debbie ^a   Wilson, Karen ^a   Miggans, Sharon T ^a   McCartney, Mitchell D ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

cytoskeleton; dexamethasone; microfilaments; tetrahydrocortisol; trabecular meshwork

Indexed keywords

CORTODOXONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR AGONIST; GLUCOCORTICOID RECEPTOR ANTAGONIST; HORMONE RECEPTOR AFFECTING AGENT; HYDROCORTISONE; PREDNISOLONE; PROGESTERONE; SESAME SEED OIL; TETRAHYDROCORTISOL; TRIAMCINOLONE ACETONIDE; TRITIUM; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HYPERTENSION; INTRAOCULAR HYPERTENSION; MICROFILAMENT; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRABECULAR MESHWORK; WEIGHT REDUCTION;

ACTINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; BODY WEIGHT; CELL LINE; CELLS, CULTURED; CYTOSKELETON; DEXAMETHASONE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERTENSION; INTRAOCULAR PRESSURE; MICROSCOPY, IMMUNOELECTRON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; TETRAHYDROCORTISOL; TRABECULAR MESHWORK; TUBULIN;

EID: 0029878484     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500-507.
2. Armaly MF. Effect of corticosteroids on intra ocular and fluid dynamics: I: The effect of dexamethasone in the normal eye. Arch Ophthalmol. 1963;70:482-491.
3. Kass MA, Johnson T. Corticosteroid-induced glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St. Louis: CV Moshy; 1989;1161-1168.
4. Bernstein NH, Schwartz B. Effects of long-term systemic steroids on ocular pressure and tonographic values. Arch Ophthalmol. 1962;68:742-753.
5. Francois J. Cortisone et tension oculaire. Ann Ocul. 1954;187:805-816. In French.
6. Goldmann H. Cortisone glaucoma. Arch Ophthalmol. 1962;68:621-626.
7. Shields MB. Textbook of Glaucoma. 3rd ed. Baltimore: Williams & Wilkins; 1992:374-380.
8. Johnson DH, Bradley JMB, Acott TS. The effect of dexamethasone on glycosaminoglycans of the human trabecular meshwork in perfusion organ culture. Invest Ophthalmol Vis Sci. 1990;31:2568-2571.
9. Johnson DH, Bradley JM, Scott TS, Fauss DJ, Polansky JR. The effect of steroids on human trabecular meshwork in perfusion organ culture. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1989;30:223.
10. Rohen JW, Linner E, Winner R. Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-glaucoma. Exp Eye Res. 1973;17:19-31.
11. Roll R, Benedikt O. Electronmicroscopic investigation of the trabecular meshwork in cortisonglaucoma. Klin Mbl Augenheilk. 1979;174:421-428.
12. Toriyama K. An electron microscopic study on the trabecular meshwork in corticosteroid-glaucoma. Folia Ophthalmol Jpn. 1979;30:1583-1589.
13. Lorenzetti OJ. Effects of corticosteroids on ocular dynamics in rabbits. J Pharmacol Exp Ther. 1970;175:763-772.
14. Knepper PA, Breen M, Weinstein HG, Blacik LJ. Intraocular pressure and glycosaminoglycan distribution in the rabbit eye: Effect of age and dexamethasone. Exp Eye Res. 1978;27:567-575.
15. Zhan G-L, Miranda OC, Bito LZ. Steroid glaucoma: Corticosteroid-induced ocular hypertension in cats. Exp Eye Res. 1992;54:211-218.
16. Palkama A, Alaranta S, Oksala O, Krootila K, Virtanen I, Uusitalo H. Glucocorticoid induced glaucoma in the cat eye. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;35:2774.
17. DeSantis L, Garthwaite C, Knepper PA. Dexamethasone-induction of ocular hypertension in the primate. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1990;31:99.
18. Polansky JR, Kurtz RM, Fauss DJ, Kim RY, Bloom E. In vitro correlates of glucocorticoid effects on intraocular pressure. In: Krieglstein GK, ed. Glaucoma Update IV. Berlin: Springer-Verlag; 1991:20-29.
19. Tripathi BJ, Millard CB, Tripathi RC. Corticosteroids induce a sialated glycoprotein (Cort-GP) in trabecular cells in vitro. Exp Eye Res. 1990;51:735-737.
20. Steely HT, Browder SL, Julian MB, Miggans ST, Wilson KL, Clark AF. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1992;33: 2242-2250.
21. Yun AJ, Murphy CG, Polansky JR, Newsome DA, Alvarado JA. Proteins secreted by human trabecular cells: Glucocorticoid and other effects. Invest Ophthalmol Vis Sci. 1989;30:2012-2022.
22. Snyder RW, Stamer WD, Kramer TR, Seftor REB. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp Eye Res. 1993;57:461-468.
23. Samples JR, Alexander JP, Fisk A, Acott TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by Interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci. 1993;34:3386-3395.
24. Wilson K, McCartney MD, Miggans ST, Clark AF. Dexamethasone induced ultrastructural changes in cultured human trabecular meshwork cells. Curr Eye Res. 1993;12:783-793.
25. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, Howe W. Glucocorticoid-induced cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-293.
26. Tripathi BJ, Tripathi RC, Swift HH. Hydrocortisone-induced DNA endoreplication in human trabecular cells in vitro. Exp Eye Res. 1989;49:259-270.
27. Shirato S, Bloom E, Polansky J, Alvarado J, Stilwell L. Phagocytic properties of confluent cultured human trabecular meshwork cells. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1988;29:125.
28. Treister G, Manner S. Intraocular pressure and outflow facility: effect of estrogen and combined estrogen-progestin treatment in normal human eyes. Arch Ophthalmol. 1970;83:311-318.
29. Green K, Phillips CI, Gore SM, Elijah RJD, Bowman KA, Cullen P. Ocular fluid dynamics response to topical RU486, a steroid blocker. Curr Eye Res. 1985;4:605-612.
30. Witzmann R, Effect of spironolactone on intraocular pressure in glaucoma patients. Klin Monatsbl Augenheilkd. 1980;177:445-446.
31. Lamble JW, Lamble AP. Some effects of progestogens, oestrogens and androgens on the ocular tension of rabbits and owl monkeys. Exp Eye Res. 1978;26:599-610.
32. Southren AL, l'Hommedieu D, Gordon GG, Weinstein BI. Intraocular hypotensive effect of a topically applied cortisol metabolite: 3α,5β-tetrahydrocortisol. Invest Ophthalmol Vis Sci. 1987;28:901-903.
33. Southren AL, Wandel T, Gordon GG, Weinstein BI. Treatment of glaucoma with 3α,5β-tetrahydrocortisol: a new therapeutic modality. J Ocul Pharmacol. 1994;10:38-391.
34. Eliard PH, Rousseau GG. Thermodynamics of steroid binding to the human glucocorticoid receptor. Biochem J. 1984;218:395-404.
35. Clark AF, Miggans ST, Wilson K, Browder S, McCartney MD. Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. J Glaucoma. 1995;4:183-188.
36. Weinreb RN, Bloom E, Baxter JD, et al. Detection of glucocorticoid receptors in cultured human trabecular cells. Invest Ophthalmol Vis Sci. 1981;21:403-407.
37. Hernandez MR, Wenk EJ, Weinstein BI, et al. Glucocorticoid target cells in human outflow pathway: autopsy and surgical specimens. Invest Ophthalmol Vis Sci. 1983;24:1612-1616.
38. Clark AF. Steroids, ocular hypertension, and glaucoma. J Glaucoma. 1995;4:354-369.
39. Green K, Cheeks L, Slagle T, Phillips CI. Interaction between progesterone and mifepristone on intraocular pressure in rabbits. Curr Eye Res. 1989;8:317-320.
40. Denis P, Elena PP, Nordmann JP, Sarrieau A, Saraux H, Rostene W. Mifepristone (RU 486): In vitro binding to glucocorticoid receptors in iris-ciliary body and in vivo effects on intraocular pressure in rabbits. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1993; 34:1115.
41. Mall G, Reinhard H, Stopp D, Rossner JA. Morphometric observations on the rat heart after high dose treatment with cortisol. Virchows Arch. 1980;385:169-180.
42. Nasletti A, Erman A, Cagen LA, Baer PG. Plasma concentrations, renal excretion, and tissue release of prostaglandins in the rat with dexamethasone-induced hypertension. Endocrinology. 1984;114:1033-1040.
43. Clark AF, DeMartino GN, Wildenthal K Effects of glucocorticoid treatment on cardiac protein synthesis and degradation. Am J Physiol. 1986;250:C821-C827.
44. Konagaya M, Bernard PA, Max SR. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology. 1986;119:375-380.
45. McCartney MD, Wilson K, Miggans ST, Clark AF. Effect of dexamethasone and tetrahydrocortisol on cultured human trabecular meshwork cell microfilament and microtubule structure. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;35:2735.
46. Kawase K, Steely HT, Clark AF. The effects of dexamethasone and tetrahydrocortisol on protein expression in cultured human trabecular meshwork cells. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994; 35:2734.
47. Clark AF, McNatt L, Knepper PA. Angiostatic steroids as a new class of IOP lowering compounds. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;35:1057.